Anna Clark, ProPublica

Most recent articles by Anna Clark, ProPublica

FDA finally moves to scrutinize specialized health screenings
FDA finally moves to scrutinize specialized health screenings
Anna Clark, ProPublica
May 1, 2024
1:30 pm

The agency issued a rule that brings new scrutiny to a range of critical lab-developed tests, including certain cancer and prenatal screenings. ProPublica previously reported how lab-test accuracy and marketing had skirted federal oversight.

Scores of critical lab tests fall into a regulatory void. The FDA is trying to close it.
Scores of critical lab tests fall into a regulatory void. The FDA is trying to close it.
Anna Clark, ProPublica
June 15, 2023
11:00 am

Lab-developed tests like prenatal screenings have become increasingly popular, all while escaping the bulk of federal scrutiny over marketing and accuracy. Now, the FDA is beginning the process of imposing regulations on these kinds of tests.

The tests are vital. But Congress decided that regulation is not.
The tests are vital. But Congress decided that regulation is not.
Anna Clark, ProPublica
January 24, 2023
12:00 pm

Money and lobbying help shield lab-developed tests, including prenatal screenings, from heightened federal scrutiny.

  • From Our Partners